# OSIRIS THERAPEUTICS, INC.

OSIRIS THERAPEUTICS, INC. is a company headquartered in Columbia, MD, United States.

## Company overview

- **Legal name:** OSIRIS THERAPEUTICS, INC.
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Columbia, MD, United States
- **Incorporated in:** MD
- **Fiscal year end:** December 31
- **SEC CIK:** 0001360886

## About

OSIRIS THERAPEUTICS, INC. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001360886, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2019-03-15, it reported annual revenue of USD 142,824,000; total assets of USD 101,502,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $142.8M (USD 142,824,000)
- **Total assets:** $101.5M (USD 101,502,000)
- **Cash and equivalents:** $16.4M (USD 16,367,000)
- **Operating cash flow:** $7.3M (USD 7,304,000)

### FY2017 (period ended 2017-12-31)

- **Total assets:** $78.1M (USD 78,122,000)
- **Cash and equivalents:** $3.1M (USD 3,081,000)
- **Operating cash flow:** -$5.2M (USD -5,223,000)

### FY2014 (period ended 2014-12-31)

- **Total assets:** $98.1M (USD 98,118,000)
- **Cash and equivalents:** $2.2M (USD 2,208,000)
- **Operating cash flow:** -$3.1M (USD -3,149,000)
- **Later filings:** Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-12-31)

- **Total assets:** $92.1M (USD 92,097,000)
- **Cash and equivalents:** $2.4M (USD 2,416,000)
- **Operating cash flow:** -$13.3M (USD -13,269,000)
- **Later filings:** Total assets, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2019-04-17 — period 2019-04-17 — 8-K
- Form 10-K — filed 2019-03-15 — period 2018-12-31 — 10-K
- Form 8-K — filed 2019-03-12 — period 2019-03-12 — 8-K
- Form 8-K — filed 2019-03-12 — period 2019-03-12 — 8-K
- Form 8-K — filed 2018-11-26 — period 2018-11-26 — 8-K
- Form 8-K — filed 2018-11-08 — period 2018-11-08 — 8-K
- Form 10-Q — filed 2018-11-07 — period 2018-09-30 — 10-Q
- Form 8-K — filed 2018-11-07 — period 2018-11-07 — 8-K
- Form 8-K — filed 2018-09-17 — period 2018-09-17 — 8-K
- Form 8-K — filed 2018-09-11 — period 2018-09-07 — 8-K
- Form 10-Q — filed 2018-08-08 — period 2018-06-30 — 10-Q
- Form 8-K — filed 2018-07-10 — period 2018-07-10 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/osiris-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology